ACVR1 and fibrodysplasia ossificans progressiva: All patients with FOP have gain-of-function mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1, and ~97% of FOP patients harbor a recurrent ACVR1R206H mutation (c.617G>A;p.R206H)3,4.